Corvus Pharmaceuticals (CRVS) Selling, General & Administrative (2015 - 2026)
Corvus Pharmaceuticals' Selling, General & Administrative came in at $3.33 million for Q2 2026, up 39.6% from $2.39 million a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Selling, General & Administrative (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corvus Pharmaceuticals reported Selling, General & Administrative of $11.54 million, up 32.5% year-over-year; for FY2023, it came in at $6.88 million, down 15.0% from FY2022.
- Selling, General & Administrative has declined in each of the last three years, with a five-year compound annual growth rate of -8.3% (FY2018 to FY2023).
- Going back by year, Selling, General & Administrative was $8.1 million in FY2022 (-14.9%), $9.52 million in FY2021 (-20.2%), $11.93 million in FY2020 (+9.7%) and $10.88 million in FY2019 (+2.3%).
- The five-year range for quarterly Selling, General & Administrative is $1.59 million (Q4 2022) to $3.7 million (Q1 2026).
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2026 (growth of 49.9%), and the weakest in Q3 2021 (a decline of 36.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Corvus Pharmaceuticals | 919.44 Mn | 407.88 Mn | - | 3.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.33 Mn |
| Mar 31, 2026 | 3.70 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.47 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 2.18 Mn |
| Mar 31, 2021 | 3.25 Mn |
API Access
Corvus Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();